Literature DB >> 3639057

Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.

B Hägglöf, G Holmgren, G Holmlund, B Lindblom, B Olaisen, P Teisberg.   

Abstract

The HLA-A,-B,-C,-DR antigens and the complement factors C2, C4 and Bf were determined in 30 insulin-dependent diabetes mellitus (IDDM) patients and 30 healthy controls from northern Sweden. Family studies allowed the deduction of extended haplotypes in the HLA and complement systems. Phenotype studies revealed significant associations between IDDM and HLA-DR4 (p less than 0.001), HLA-DR3 (p less than 0.05), HLA-DR3/4 (p less than 0.025), C4-B3 (p less than 0.001) and Bf-S (p less than 0.025). Haplotype studies showed that the extended haplotype [HLA-B15, C2-1, C4-A3B3, Bf-S, HLA-DR4] had a particularly strong association to IDDM. This haplotype was found in 10 out of 30 IDDM probands but in none of 30 control children and accounts for practically all the C4-B3 allotypes among the 30 IDDM probands. The C4-B3 gene therefore seems to be a valuable marker for IDDM. No haplotype containing HLA-DR3 was increased in frequency among the IDDM probands. The extended haplotype [HLA-B7, C2-1, C4-A3B1, Bf-S, HLA-DR2] present among the controls was absent in the IDDM probands. The frequency of the extended haplotype [HLA-B15, C2-1, C4-A3B3, Bf-S, HLA-DR4] was increased also among the parents to the IDDM probands compared to those of the control parents, whereas the frequency of [HLA-B7, C2-1, C4-A3B1, Bf-S, HLA-DR2] was decreased. The extended haplotype [HLA-B8, C2-1, C4-B1, Bf-S, HLA-DR3] was more common among the males (p less than 0.05) compared to the females in the total material. The family analysis showed that 3 out of 5 affected sibs shared both haplotypes with their IDDM proband. This was the case for only 3 out of 35 unaffected sibs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3639057     DOI: 10.1159/000153627

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  9 in total

1.  Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

Authors:  Tamara Montes; Agustín Tortajada; B Paul Morgan; Santiago Rodríguez de Córdoba; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

2.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

3.  Trichorhinophalangeal syndrome type I and systemic lupus erythematosus with complement C4A homozygous null alleles in the same family.

Authors:  S R Dahlqvist; B Lundström; G Holmgren
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

4.  A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Fennessy; K Metcalfe; G A Hitman; M Niven; P A Biro; J Tuomilehto; E Tuomilehto-Wolf
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.

Authors:  M Thomsen; J Mølvig; A Zerbib; C de Preval; M Abbal; J M Dugoujon; E Ohayon; A Svejgaard; A Cambon-Thomsen; J Nerup
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.

Authors:  I Kockum; R Wassmuth; E Holmberg; B Michelsen; A Lernmark
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

7.  Inheritance of MHC class II genes in IDDM studied in population-based affected and control families.

Authors:  I Kockum; R Wassmuth; E Holmberg; B Michelsen; A Lernmark
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

Review 8.  The complotype: dictating risk for inflammation and infection.

Authors:  Claire L Harris; Meike Heurich; Santiago Rodriguez de Cordoba; B Paul Morgan
Journal:  Trends Immunol       Date:  2012-06-29       Impact factor: 16.687

9.  Increased complement activation in human type 1 diabetes pancreata.

Authors:  Patrick Rowe; Clive Wasserfall; Byron Croker; Martha Campbell-Thompson; Alberto Pugliese; Mark Atkinson; Desmond Schatz
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.